We found upregulation (about 3 times higher) of RBP4 in sera of benign ovarian tumor patients and myoma patients from healthy control patients (P < 0.05), while no significant difference was detected between RBP4 in the sera from patients with ovarian tumor and myoma (P > 0.05). This evidence concerns the gene RBP4 and benign muscle neoplasm.